An Investigational Immuno-therapy Study to Investigate the Safety and Effectiveness of Nivolumab, and Nivolumab Combination Therapy in Virus-associated Tumors

Local Institution - 0012, Brussels

Local Institution - 0014, Brussels

Local Institution - 0013, Brussels

Local Institution - 0026, Taipei

Local Institution - 0036, New York

Local Institution - 0031, Marseille

Local Institution - 0029, Pittsburgh

Local Institution - 0023, Lutherville

Local Institution - 0017, Madrid

Local Institution - 0022, Charlotte

Local Institution - 0003, Atlanta

Local Institution - 0016, Navarra

Local Institution - 0032, Toulouse

Local Institution - 0027, Essen

Local Institution - 0035, Ann Arbor

Local Institution - 0001, Sioux Falls

Local Institution, Oaxaca City

Local Institution - 0037, Tainan City

Local Institution - 0005, Oklahoma City

Local Institution - 0028, Heilbronn

Local Institution - 0038, Paris

Local Institution - 0030, Vlllejuif

Local Institution - 0046, Mérida

Local Institution - 0004, Portland

Local Institution - 0021, Seattle

Local Institution - 0040, Chuo-ku

Local Institution - 0039, Kashiwa-shi

Local Institution - 0033, Tampa

Local Institution - 0002, Boston

Local Institution - 0019, Boston

Local Institution - 0020, Boston

Local Institution - 0041, Koto-ku

Local Institution - 0056, Mexico City

Local Institution - 0011, Amsterdam

Local Institution - 0034, Utrecht

Local Institution - 0024, Seoul

Local Institution - 0018, Barcelona

Local Institution - 0006, Glasgow

Local Institution - 0010, Birmingham

Local Institution - 0008, London